Showbiz Cheat Sheet
2019 Showbiz Cheat Sheet,
All Rights Reserved.
Articles About novartis
Is Pfizer Poised to Head Higher?
Where Will GlaxoSmithKline Go Next?
Novartis Recalls More Than 5 Million Physicians’ Samples
Is GlaxoSmithKline an Attractive Investment?
Will Recent Headlines Take Merck Higher?
Where Will Johnson & Johnson Go Next?
Does Pfizer Have a Bright Future?
Novartis Optimistic About New Cancer Treatment
Will GlaxoSmithKline Head Higher After Recent Headlines?
Can Pfizer Continue to Outperform?
Christmas Comes Early for Novartis Investors
Pfizer Feels the Heat From Novartis
Will Recent News Hurt Johnson & Johnson?
Is Johnson & Johnson a Buy at These Prices?
4 Merger and Acquisitions Stock Stories Making Monday Moves
Twitter Cools Off, Loeb’s Stake in Sony, and 3 More Hot Stocks
Washington State Wants Boeing 777, Bank of America’s Big Fine: Morning Buzzers
Will the New Arthritis Drug Help Celgene Surge Higher?
Boeing Will Make Key 777X Parts in Seattle and 2 Other Dow Movers to Watch
Will GlaxoSmithKline Continue to Trend Higher?
4 Healthcare Stock Stories Ready for a Tuesday Investment Checkup
Tesla’s Strong China Demand, DirecTV’s Solid Quarter, and 3 More Hot Stocks
Can Pfizer Continue to Trend Higher?
Does Merck Have a Bright Future?
Will Celgene Continue to Trade at All-Time Highs?
Apple’s iPad Gets Its Turn, ARM Holdings Sinks on Solid Quarter, and 3 More Hot Stocks
3 Healthcare Stock Stories Recommended for Investment Wellness
4 Healthcare Stock Stories to Begin a Week of Investment Wellness
JPMorgan’s Net Loss, Wells Fargo’s Mixed Quarter, and 3 More Hot Stocks
Does Johnson & Johnson Support Higher Prices?
Analysts: Apple’s iPhone 5S in High Demand and 3 Other Research Notes to Browse
Can Pfizer Stock Keep Going?
Bribery Scandal Hits Novartis, Adobe Wins On the Cloud: Market Recap
Here’s Another Chinese Bribery Scandal for Novartis
Apple TV Gets a Nod from AirPlay, Pandora’s New Share Offering, and 3 More Hot Stocks
Can GlaxoSmithKline Continue to Rise?
Chrylser’s IPO, Boeing’s South Korea Deal: Morning Buzzers
Is Johnson & Johnson a Worthwhile Investment?
Can GlaxoSmithKline Get Past Recent Headlines?
Can Johnson & Johnson Continue This Bull Run?
4 Healthcare Stock Stories for a Tuesday Investment Checkup
Icahn May Pressure Apple Acquisition, Shell’s New Facility, and 3 More Hot Stocks
4 Healthcare Stock Stories To Further Investment Wellness On Thursday
4 Merger and Acquisitions Stock Stories for Tuesday Due Diligence
Why Is Novartis in Trouble in Japan?
4 Healthcare Stock Stories For a Midweek Investment Checkup
Does Pfizer Support a Surge Higher?
Does GlaxoSmithKline Stock Support Rising Prices?
Microsoft Uses Sprint Help to Launch New Windows Phone and 2 Other Dow Movers to Watch
Is Novartis a Buy after Earnings?
Dell and Silver Lake’s Bid Refusal, PepsiCo’s Time with Peltz is Up, and 3 More Hot Stocks
Barclays Fights Fine, Dell Won’t Raise Bid: Morning Buzzers
Can GlaxoSmithKline Break Higher?
Can GlaxoSmithKline Get Past This Hiccup and Head Higher?
3 Healthcare Stock Stories To End the Trading Week
Tesla Sees Big Opportunity in Hong Kong, Diageo Expands United Stake, and 3 More Hot Stocks
Onyx is on the Prowl for a Pharmaceuticals Partner After Rejecting Amgen’s Low-Ball Offer